SU1087076A3 - Способ получени производных цефалоспорина - Google Patents

Способ получени производных цефалоспорина Download PDF

Info

Publication number
SU1087076A3
SU1087076A3 SU813336819A SU3336819A SU1087076A3 SU 1087076 A3 SU1087076 A3 SU 1087076A3 SU 813336819 A SU813336819 A SU 813336819A SU 3336819 A SU3336819 A SU 3336819A SU 1087076 A3 SU1087076 A3 SU 1087076A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
formula
hydrogen
substituted
alkyl
Prior art date
Application number
SU813336819A
Other languages
English (en)
Russian (ru)
Inventor
Самуэль Катнер Аллен
Original Assignee
Эли Лилли Энд Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани (Фирма) filed Critical Эли Лилли Энд Компани (Фирма)
Application granted granted Critical
Publication of SU1087076A3 publication Critical patent/SU1087076A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SU813336819A 1980-09-17 1981-09-16 Способ получени производных цефалоспорина SU1087076A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/187,859 US4346076A (en) 1980-09-17 1980-09-17 Bis-tetrazoylmethyl substituted cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
SU1087076A3 true SU1087076A3 (ru) 1984-04-15

Family

ID=22690789

Family Applications (2)

Application Number Title Priority Date Filing Date
SU813336819A SU1087076A3 (ru) 1980-09-17 1981-09-16 Способ получени производных цефалоспорина
SU823480177A SU1119607A3 (ru) 1980-09-17 1982-08-20 Способ получени производных цефалоспорина

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU823480177A SU1119607A3 (ru) 1980-09-17 1982-08-20 Способ получени производных цефалоспорина

Country Status (22)

Country Link
US (1) US4346076A (enExample)
EP (1) EP0048169A3 (enExample)
JP (1) JPS5781492A (enExample)
KR (1) KR830007688A (enExample)
AU (1) AU7528481A (enExample)
CA (1) CA1174668A (enExample)
CS (1) CS686781A2 (enExample)
DD (1) DD201142A5 (enExample)
DK (1) DK412181A (enExample)
ES (1) ES8306377A1 (enExample)
FI (1) FI812782L (enExample)
GB (1) GB2084144B (enExample)
GR (1) GR74671B (enExample)
HU (1) HU185954B (enExample)
IL (1) IL63770A0 (enExample)
PH (1) PH16985A (enExample)
PL (1) PL132001B1 (enExample)
PT (1) PT73680B (enExample)
RO (1) RO82970B (enExample)
SU (2) SU1087076A3 (enExample)
YU (1) YU222681A (enExample)
ZA (1) ZA816224B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850001206B1 (ko) * 1984-04-27 1985-08-20 한국과학기술원 세펨 유도체의 제조 방법
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
EP0333082A3 (en) * 1988-03-15 1991-05-02 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
JPS525787A (en) * 1975-06-27 1977-01-17 Bristol Myers Co Antiibacterial agent
US4109083A (en) * 1976-02-17 1978-08-22 Pfizer Inc. 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4121040A (en) * 1976-02-17 1978-10-17 Pfizer Inc. 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4129732A (en) * 1977-04-27 1978-12-12 Pfizer Inc. 4(Tetrazol-5-yl)-Δ3 -cephem compounds
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Патент JP № 54-42999, кл. С 07 D 501/36, опублик. 1979. *

Also Published As

Publication number Publication date
CA1174668A (en) 1984-09-18
YU222681A (en) 1983-10-31
GB2084144B (en) 1985-02-06
GB2084144A (en) 1982-04-07
GR74671B (enExample) 1984-07-02
CS686781A2 (en) 1985-06-13
EP0048169A3 (en) 1983-01-19
PT73680A (en) 1981-10-01
FI812782A7 (fi) 1982-03-18
ES505550A0 (es) 1983-05-16
JPS5781492A (en) 1982-05-21
PL132001B1 (en) 1985-01-31
HU185954B (en) 1985-04-28
RO82970A (ro) 1984-01-14
US4346076A (en) 1982-08-24
PL233058A1 (enExample) 1982-10-11
ES8306377A1 (es) 1983-05-16
AU7528481A (en) 1982-03-25
DK412181A (da) 1982-04-21
IL63770A0 (en) 1981-12-31
EP0048169A2 (en) 1982-03-24
DD201142A5 (de) 1983-07-06
RO82970B (ro) 1984-01-30
KR830007688A (ko) 1983-11-04
PH16985A (en) 1984-05-04
PT73680B (en) 1982-11-26
SU1119607A3 (ru) 1984-10-15
FI812782L (fi) 1982-03-18
ZA816224B (en) 1983-04-27

Similar Documents

Publication Publication Date Title
CA1283404C (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
SU1303029A3 (ru) Способ получени производных цефалоспорина
FI65432C (fi) Foerfarande foer framstaellning av antibakteriella 7beta-arylmalonamido-7alfa-metoxi-3-tiadiazolyltiometyl-1-detia-1-oxa-3-cefem-4-karbonsyror eller derivat daerav
JPS6220191B2 (enExample)
KR830000853B1 (ko) 아실 유도체의 제조방법
NO165027B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
GB2105335A (en) Cephalosporin quinolinium betaines
US4396619A (en) Cephalosporin betaines
HU187575B (en) Process for the preparation of cephem-carboxylic acid derivatives substituted by thienopyridinium-methyl and furopyridinium-methyl group
US4785090A (en) Cephalosporin derivatives
CA1225390A (en) 3-bicyclicpyridinium-methyl cephalosporins
US4406898A (en) Oxazole and oxadiazole cephalosporins
SU1087076A3 (ru) Способ получени производных цефалоспорина
CA1279868C (en) 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof
US4226864A (en) 7-Substituted aminoacetamido oxadethiacephalosporins
EP0329785B1 (en) Cephalosporin derivatives
US4880798A (en) Cephalosporin derivatives
US4059578A (en) 7-Substituted mercaptoacetamido cephamycins
US4382931A (en) 3'-Substituted quinolinium cephalosporins
JPS6247874B2 (enExample)
SE416472B (sv) Forfarande for framstellning av 7-(alfa-amino-p-hydroxifenylacetamido)-3-(1,2,3-triazolyltiometyl)-3-cefem-4-karboxylsyror
SU1575940A3 (ru) Способ получени карбацефалоспориновых соединений
US4179502A (en) 7[2-Hydroxyiminoacetamido]cephalosporins
US4198504A (en) [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives
EP0605836A1 (en) Cephalosporin derivatives